ผู้เขียน หัวข้อ: Contribution To Literature  (อ่าน 13 ครั้ง)

habits

  • Jr. Member
  • **
  • กระทู้: 135
Contribution To Literature
« เมื่อ: พฤษภาคม 09, 2021, 22:36:41 »
UFABET
The DAPA-HF trial showed that dapagliflozin was superior to placebo at preventing cardiovascular deaths and heart failure events.

Description:
The goal of the trial was to evaluate dapagliflozin (a sodium-glucose cotransporter 2 [SGLT2] inhibitor) compared with placebo among patients with heart failure with reduced ejection fraction (HFrEF).

Study Design
Randomized
Parallel
Placebo